Human enhancement drugs and the pursuit of perfection.

The emerging threat to public health posed by the use of human enhancement drugs has remained largely unrecognised. In attempts to become stronger, happier or smarter, or to look thinner, younger or more beautiful, people are turning to a diverse range of pharmaceuticals. The widespread availability of drugs with the potential to improve human attributes, appearance and abilities has generated a new and growing audience of users. Unlike users of drugs such as heroin, cocaine etc, users of human enhancement drugs do not necessarily perceive themselves as 'drug users'. Those attracted to these drugs may have little or no knowledge or understanding of the physical or psychological harm associated with these substances or their potential for addiction. In addition to the potent effects of many human enhancement drugs, there are considerable risks associated to the clandestine nature of the market. The growing number of untested, banned or adulterated drugs and the lack of safeguards and quality assurance in the illicit manufacturing process has resulted in serious harms and fatalities. The ease with which pharmaceuticals can be manufactured and distributed, combined with the significant profits that can be made from the illicit market, has resulted in a growing challenge for policy makers and health systems in many countries. This editorial aims to raise awareness of this emerging drugs situation and provide a brief overview of some of the drugs and their associated risks.

[1]  Julian Savulescu,et al.  Enhancing human capacities , 2011 .

[2]  K. Zou,et al.  Characteristics, behaviors, and attitudes of men bypassing the healthcare system when obtaining phosphodiesterase type 5 inhibitors. , 2010, The journal of sexual medicine.

[3]  J. Honour,et al.  Analysis of Corticosteroids , 2010 .

[4]  T. Y. Chan Outbreaks of severe hypoglycaemia due to illegal sexual enhancement products containing undeclared glibenclamide , 2009, Pharmacoepidemiology and drug safety.

[5]  J. McVeigh,et al.  Injecting human growth hormone as a performance-enhancing drug—perspectives from the United Kingdom , 2009 .

[6]  Andreas Kimergård,et al.  Elephant in the room? The methodological implications for public health research of performance-enhancing drugs derived from the illicit market. , 2009, Drug testing and analysis.

[7]  J. McVeigh,et al.  Use of melanotan I and II in the general population , 2009, BMJ : British Medical Journal.

[8]  Peter Conrad,et al.  The Medicalization of Society: On the Transformation of Human Conditions into Treatable Disorders , 2007 .

[9]  G. Lau,et al.  1. A Fatal Case of Hepatic Failure Possibly Induced by Nitrosofenfluramine , 2004 .

[10]  G. Lau,et al.  A fatal case of hepatic failure possibly induced by nitrosofenfluramine: a case report. , 2004, Medicine, science, and the law.

[11]  J. Savill,et al.  Membranous nephropathy caused by mercury-containing skin lightening cream. , 1987, Postgraduate medical journal.

[12]  V. Berridge Victorian opium eating: responses to opiate use in nineteenth century society. , 1978, The Society for the Social History of Medicine bulletin.

[13]  J. Young The medical messiahs : a social history of health quackery in twentieth-century America , 1968 .

[14]  P. Cannon,et al.  PATHOLOGIC EFFECTS OF ELIXIR OF SULFANILAMIDE (DIETHYLENE GLYCOL) POISONING: A CLINICAL AND EXPERIMENTAL CORRELATION: FINAL REPORT , 1938 .